OTCMKTS:IPSEY IPSEN (IPSEY) Stock Price, News & Analysis $46.81 +0.00 (+0.00%) As of 11/13/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendNews and TrendsShort Interest About IPSEN Stock (OTCMKTS:IPSEY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IPSEN alerts:Sign Up Key Stats Today's Range$46.81▼$46.8150-Day Range$39.75▼$46.8152-Week Range$34.34▼$51.10Volume4 shsAverage Volume1,608 shsMarket Capitalization$15.69 billionP/E RatioN/ADividend Yield0.64%Price TargetN/AConsensus RatingHold Company Overview IPSEN is a global biopharmaceutical company headquartered in France. Founded in 1929, it develops and commercializes medicines focused on oncology, rare diseases and neuroscience. Its portfolio includes treatments such as Somatuline for certain neuroendocrine tumors and acromegaly, Dysport for several neurological and aesthetic uses, and Cabometyx for certain cancers. The company also conducts research and development to advance medicines across its therapeutic areas. IPSEN serves patients and healthcare professionals in countries around the world through its international commercial operations and partnerships.AI Generated. May Contain Errors. Read More IPSEN Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreIPSEY MarketRank™: 0.74076543539 of 5 starsIPSEN scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingIPSEN has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and 2 sell ratings.Amount of Analyst CoverageIPSEN has only been the subject of 1 research reports in the past 90 days.Read more about IPSEN's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth0.25% Earnings GrowthEarnings for IPSEN are expected to grow by 0.25% in the coming year, from $3.94 to $3.95 per share.Price to Book Value per Share RatioIPSEN has a P/B Ratio of 3.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of IPSEN has been sold short.Short Interest Ratio / Days to CoverIPSEN has a short interest ratio ("days to cover") of 0.13, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IPSEN has recently increased by 2.31%, indicating that investor sentiment is decreasing. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldIPSEN has a dividend yield of 0.64%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthIPSEN does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, IPSEN will have a dividend payout ratio of 7.59% next year. This indicates that IPSEN will be able to sustain or increase its dividend.Read more about IPSEN's dividend. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 3 news articles for IPSEN this week, compared to 1 article on an average week.MarketBeat Follows2 people have added IPSEN to their MarketBeat watchlist in the last 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IPSEN insiders have not sold or bought any company stock.Percentage Held by InstitutionsIPSEN has minimal institutional ownership at this time.Read more about IPSEN's insider trading history. Receive IPSEY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IPSEN and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IPSEY Stock News HeadlinesFY2026 Earnings Estimate for IPSEN Issued By HC WainwrightNovember 14, 2026 | americanbankingnews.comIPSEN (OTCMKTS:IPSEY) Stock Rated "Hold" by Wall Street BrokeragesNovember 10, 2026 | americanbankingnews.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out. | Weiss Ratings (Ad)Ipsen Reports October Share and Voting Rights TotalsNovember 6, 2026 | tipranks.comIQIRVO® late-breaking data raises ambitions in PBC with more than 85% of patients on treatment achieving ALP normalizationNovember 5, 2026 | finance.yahoo.comIpsen SA Q3 Total Sales Rise 28%; Upgrades FY26 OutlookOctober 22, 2026 | rttnews.comIpsen SA - depositary receipt price target increased by 31.77% to $47.34October 22, 2026 | msn.comIpsen delivers outstanding sales growth in the first nine months of 2026 and further upgrades its full-year guidanceOctober 22, 2026 | markets.businessinsider.comSee More Headlines IPSEY Stock Analysis - Frequently Asked Questions How have IPSEY shares performed this year? IPSEN's stock was trading at $36.3596 at the beginning of the year. Since then, IPSEY stock has increased by 28.7% and is now trading at $46.8080. How do I buy shares of IPSEN? Shares of IPSEY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IPSEN own? Based on aggregate information from My MarketBeat watchlists, some other companies that IPSEN investors own include Bilibili (BILI), AbbVie (ABBV), CVS Health (CVS), Halliburton (HAL), Adidas (ADDYY), Ageas (AGESY) and AutoCanada (ACQ). Company Calendar Today11/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:IPSEY CIKN/A Webwww.ipsen.com Phone(315) 833-5000Fax33-01-58-33-50-01Employees5,535Year Founded1929Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.16 billion Price / Sales3.77 Cash Flow$5.51 per share Price / Cash Flow8.49 Book Value$14.64 per share Price / Book3.20Miscellaneous Outstanding Shares335,260,000Free FloatN/AMarket Cap$15.69 billion OptionableNot Optionable Beta0.41 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:IPSEY) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredAmerica's Biggest Bank… Down?About 4,800 Chase customers reported problems in just 15 minutes on Monday. Many couldn't log in or move money...Decentralized Masters | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IPSEN Please log in to your account or sign up in order to add this asset to your watchlist. Share IPSEN With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.